Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?

被引:95
作者
Guckenberger, Matthias [1 ]
Kestin, Larry L. [2 ]
Hope, Andrew J. [3 ]
Belderbos, Jose [4 ]
Werner-Wasik, Maria [5 ]
Yan, Di [2 ]
Sonke, Jan-Jakob [4 ]
Bissonnette, Jean Pierre [3 ]
Wilbert, Juergen [1 ]
Xiao, Ying [5 ]
Grills, Inga S. [2 ]
机构
[1] Univ Hosp Wuerzburg, Dept Radiat Oncol, D-97080 Wurzburg, Germany
[2] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI USA
[3] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[4] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[5] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
关键词
Non-small cell lung cancer; Stereotactic body radiotherapy; Pulmonary function; AIR-FLOW OBSTRUCTION; RADIATION-THERAPY; CAPACITY PREDICTS; NATURAL-HISTORY; SURVIVAL; TIME; SEGMENTECTOMY; LOBECTOMY; RESECTION; DYSPNEA;
D O I
10.1097/JTO.0b013e31824165d7
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Introduction: To evaluate the influence of pretreatment pulmonary function (PF) on survival, early and late pulmonary toxicity after stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer. Methods: Four hundred eighty-three patients with 505 tumors of early-stage non-small cell lung cancer cT1-3 cN0 were treated with image-guided SBRT at five international institutions (1998-2010). Sixty-four percent of the tumors were biopsy-proven and 18F-fluorodeoxyglucose-positron emission tomography was performed for staging in 84%. Image-guided SBRT was performed with a median of three fractions to a median total dose of 54 Gy. Pretreatment PF was available for 423 patients, and 617 posttreatment PF tests from 270 patients were available. Results: A large variability of pretreatment PF was observed: the 90% range of forced expiratory volume in 1 second and diffusing capacity for carbon monoxide was 29 to 109% and 5.5 to 19.1 ml/min/mmHg, respectively. PF was significantly correlated with overall survival but not cause-specific survival: diffusing capacity for carbon monoxide of 11.2 ml/min/mmHg differentiated between 3-year overall survival of 66% and 42%. Radiation-induced pneumonitis grade >= II occurred in 7% of patients and was not increased in patients with lower PF. A significant and progressive change of PF was observed after SBRT: PF decreased by 3.6% and 6.8% on average within 6 and 6 to 24 months after SBRT, respectively. Changes of PF after SBRT were significantly correlated with pretreatment PF: PF improved for worst pretreatment PF and the largest loss was observed for best pretreatment PF. Conclusions: Image-guided SBRT is safe in terms of acute and chronic pulmonary toxicity even for patients with severe pulmonary comorbidities. SBRT should be considered as a curative treatment option for inoperable patients with pretreatment PF as reported in this study.
引用
收藏
页码:542 / 551
页数:10
相关论文
共 38 条
[1]
[Anonymous], 1995, Ann. Thorac. Surg, DOI 10.1016/0003-4975
[2]
[Anonymous], 2001, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD002935
[3]
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study [J].
Baumann, Pia ;
Nyman, Jan ;
Hoyer, Morten ;
Gagliardi, Giovanna ;
Lax, Ingmar ;
Wennberg, Berit ;
Drugge, Ninni ;
Ekberg, Lars ;
Friesland, Signe ;
Johansson, Karl-Axel ;
Lund, Jo-Asmund ;
Morhed, Elisabeth ;
Nilsson, Kristina ;
Levin, Nina ;
Paludan, Merete ;
Sederholm, Christer ;
Traberg, Anders ;
Wittgren, Lena ;
Lewensohn, Rolf .
RADIOTHERAPY AND ONCOLOGY, 2008, 88 (03) :359-367
[4]
Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy [J].
Baumann, Pia ;
Nyman, Jan ;
Hoyer, Morten ;
Wennberg, Berit ;
Gagliardi, Giovanna ;
Lax, Ingmar ;
Drugge, Ninni ;
Ekberg, Lars ;
Friesland, Signe ;
Johansson, Karl-Axel ;
Lund, Jo-Asmund ;
Morhed, Elisabeth ;
Nilsson, Kristina ;
Levin, Nina ;
Paludan, Merete ;
Sederholm, Christer ;
Traberg, Anders ;
Wittgren, Lena ;
Lewensohn, Rolf .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) :3290-3296
[5]
PROSPECTIVE, RISK-ADAPTED STRATEGY OF STEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER: RESULTS OF A PHASE II TRIAL [J].
Bral, Samuel ;
Gevaert, Thierry ;
Linthout, Nadine ;
Versmessen, Harijati ;
Collen, Christine ;
Engels, Benedikt ;
Verdries, Douwe ;
Everaert, Hendrik ;
Christian, Nicolas ;
De Ridder, Mark ;
Storme, Guy .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05) :1343-1349
[6]
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[7]
Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors [J].
Collins, Brian T. ;
Erickson, Kelly ;
Reichner, Cristina A. ;
Collins, Sean P. ;
Gagnon, Gregory J. ;
Dieterich, Sonja ;
McRae, Don A. ;
Zhang, Ying ;
Yousefi, Shadi ;
Levy, Elliot ;
Chang, Thomas ;
Jamis-Dow, Carlos ;
Banovac, Filip ;
Anderson, Eric D. .
RADIATION ONCOLOGY, 2007, 2 (1)
[8]
STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CARCINOMA: FOUR-YEAR RESULTS OF A PROSPECTIVE PHASE II STUDY [J].
Fakiris, Achilles J. ;
McGarry, Ronald C. ;
Yiannoutsos, Constantin T. ;
Papiez, Lech ;
Williams, Mark ;
Henderson, Mark A. ;
Timmerman, Robert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03) :677-682
[9]
FERGUSON MK, 1988, J THORAC CARDIOV SUR, V96, P894
[10]
Fishman A, 2003, NEW ENGL J MED, V348, P2059